LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?
about
Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes.GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2.Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradationRegulation of LRRK2 by Phosphatases.Comparative Protein Interaction Network Analysis Identifies Shared and Distinct Functions for the Human ROCO Proteins.
P2860
LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
LRRK2 Kinase Inhibition as a T ...... 's Disease, Where Do We Stand?
@en
type
label
LRRK2 Kinase Inhibition as a T ...... 's Disease, Where Do We Stand?
@en
prefLabel
LRRK2 Kinase Inhibition as a T ...... 's Disease, Where Do We Stand?
@en
P2860
P921
P1476
LRRK2 Kinase Inhibition as a T ...... 's Disease, Where Do We Stand?
@en
P2093
Elisa Greggio
P2860
P304
P356
10.2174/1570159X13666151030102847
P5008
P577
2015-10-29T00:00:00Z